Get startedLog in
    Picture of Carisma Therapeutics logo

    CARM — Carisma Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapValue Trap
    All News

    Brief: Sesen Bio Reports Third Quarter 2022 Financial Results

    Picture of Carisma Therapeutics logoCarisma Therapeutics
    07/11/2022 14:02
    Nov 7 (Reuters) - Sesen Bio Inc  SESN.O :
    * SESEN BIO REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND
BUSINESS UPDATE
    * SESEN BIO INC - QTRLY TOTAL REVENUE $40.0 MILLION
    * SESEN BIO INC - QTRLY EPS $0.10
    * SESEN BIO INC - CASH, CASH EQUIVALENTS AND MARKETABLE
SECURITIES
WERE $184.9 MILLION AS OF SEPTEMBER 30

Source text for Eikon:  ID:nBwb09Bkga 
Further company coverage:  SESN.O 
 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Carisma Therapeutics

    See all news